2007 News

November 19, 2007

Morphotek Receives U.S. Patent Regarding Methods for Generating Genetically Altered Antibodies with Enhanced Affinity and Antibodies Produced by Them
Read More

October 4, 2007

Morphotek Receives $2.7M in Funding from the National Institute of Allergy and Infectious Diseases to Develop Therapeutic Antibodies against Biowarfare Agents
Read More

September 18, 2007

Morphotek Receives $2.3M in Funding from the U.S. Department of Defense to Develop Therapeutic Antibodies Against Biowarfare Agents
Read More

June 27, 2007

Morphotek CEO Named Ernst & Young Entrepreneur Of The Year® 2007 Award Winner in Greater Philadelphia Region
Read More

May 21, 2007

Morphotek Signs Development and Clinical Supply Agreement with CMC Biopharmaceuticals A/S for Therapeutic Antibody to Treat Melanoma
Read More

April 17, 2007

Eisai Announces Completion of Acquisition of Morphotek
Read More

March 21, 2007

Eisai To Acquire Morphotek
Read More

February 13, 2007

Morphotek Obtains Exclusive License From Micromet For Antibody To Treat Melanoma and Other Cancers
Read More